Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
05/29/2013 | CN102151336B Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
05/29/2013 | CN101951964B Imaging method |
05/29/2013 | CN101878213B Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
05/29/2013 | CN101765562B Process for production of surface-coated inorganic particles |
05/28/2013 | US8450462 Compound |
05/28/2013 | US8449909 Abuse-deterrent drug formulations |
05/28/2013 | US8449866 Cellular labeling for nuclear magnetic resonance techniques |
05/28/2013 | US8449865 Drying process |
05/28/2013 | CA2575601C Methods for producing compositions comprising hyperpolarized 13c-pyruvate |
05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
05/28/2013 | CA2470597C Artificial bone mineral substitute material containing a ceramic and a water soluble non-ionic x-ray contrast agent |
05/23/2013 | WO2013072717A1 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging |
05/23/2013 | WO2013072526A1 Selective imaging of actin in live native cells |
05/23/2013 | WO2013072071A1 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging |
05/23/2013 | WO2013071413A1 Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard |
05/23/2013 | WO2013071412A1 Methods for the synthesis of 13c labeled plasmalogen |
05/23/2013 | WO2013071411A1 Methods for the synthesis of 13c labeled dha and use as a reference standard |
05/23/2013 | WO2013048022A3 Α-type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an α-type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same |
05/23/2013 | WO2013045650A3 Infusion imaging method |
05/23/2013 | WO2013022499A3 Polymer coated metal particles and uses related thereto |
05/23/2013 | US20130131354 Naphthocyanines for Use as Contrast Agents |
05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
05/23/2013 | US20130129636 Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging |
05/23/2013 | US20130129635 Polymerized shell lipid microbubbles and uses thereof |
05/23/2013 | US20130129634 Intrinsically magnetic hydroxyapatite |
05/23/2013 | US20130129633 Multimodal nanoparticles for non-invasive bio-imaging |
05/23/2013 | US20130129632 Quantum dot materials, methods for making them, and uses thereof |
05/23/2013 | US20130129631 Fluorescent Probe for Imaging Lymph Nodes |
05/23/2013 | US20130129629 Modulation of bcl11a for treatment of hemoglobinopathies |
05/23/2013 | US20130129619 Molecular Imaging of Cancer Cells In Vivo |
05/23/2013 | US20130129618 Egcg stabilized gold nanoparticles and method for making same |
05/23/2013 | US20130129616 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
05/23/2013 | US20130129614 Microorganisms for imaging and/or treatment of tumors |
05/22/2013 | EP2594568A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
05/22/2013 | EP2594290A1 Selective imaging of actin in live native cells |
05/22/2013 | EP2593186A1 Nanoparticle-guided radiotherapy |
05/22/2013 | EP2593143A1 X-ray imaging at low contrast agent concentrations and/or low dose radiation |
05/22/2013 | EP2593086A1 Lipid bilayer carrier for drugs or imaging agents |
05/22/2013 | CN103110965A Ferroferric oxide nanometer material as well as preparation method and application thereof |
05/22/2013 | CN103110964A Dual-mode contrast medium with fluorescence and magnetic resonance imaging and preparation method thereof |
05/22/2013 | CN103110963A Dual-mode synergistically-enhanced magnetic-resonance contrast agent and method for synthesizing same |
05/22/2013 | CN103110962A Traditional Chinese medicine placebo, as well as preparation process and evaluation method thereof |
05/22/2013 | CN103110961A Preparation method of high-definition endoscope mucus-removal defoaming composite preparation |
05/22/2013 | CN101721718B Lipid microbubble and preparation method thereof |
05/22/2013 | CN101678047B Remedy and diagnostic agent for mitochondrial dysfunction brain disease |
05/21/2013 | US8447386 Marker or filler forming fluid |
05/21/2013 | US8445660 Chimeric vaccines |
05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
05/21/2013 | US8445431 Ligands having metal binding ability and targeting properties |
05/21/2013 | US8445010 Abuse potential reduction in abusable substance dosage form |
05/21/2013 | US8444983 Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases |
05/21/2013 | US8444977 Assay method for Alzheimer's disease |
05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
05/21/2013 | CA2451109C Infection control system |
05/17/2013 | CA2812432A1 Methods for the synthesis of 13c labeled dha and use as a reference standard |
05/16/2013 | WO2013068896A1 Spectral imaging |
05/16/2013 | WO2012136958A8 Optical imaging probes |
05/16/2013 | US20130121929 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents |
05/16/2013 | US20130121928 Method for Diagnostically Imaging Lesions in the Peripheral Nervous System |
05/16/2013 | US20130121925 Optical determination of glucose utilizing boronic acid adducts |
05/16/2013 | US20130121924 Fluorescence detection of poison oak oil |
05/16/2013 | US20130121922 Methods for evaluating and selecting dermal filler compositions |
05/16/2013 | US20130121920 Methods for evaluating dermal filler compositions |
05/16/2013 | US20130121919 Histone acetyltransferase activators and uses thereof |
05/16/2013 | US20130121916 Compositions for Colon Lavage and Methods of Making and Using Same |
05/16/2013 | DE19941756B4 Verfahren zur Verwendung von oligomeren Nucleinsäure-Protein-Konjugaten als Reagenzien für immunologische Nachweisverfahren insbesondere die Immuno-PCR A method of using oligomeric nucleic acid-protein conjugates as reagents for immunological detection methods in particular, the Immuno-PCR |
05/15/2013 | EP2591807A1 Process for preparing a pharmaceutical formulation of contrast agents |
05/15/2013 | EP2591804A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
05/15/2013 | EP2590503A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
05/15/2013 | CN103102479A Reduction sensitive fluorescent nano micelle with FRET (Fluorescence Resonance Energy Transfer) effect and preparation method thereof |
05/15/2013 | CN103100093A Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method |
05/15/2013 | CN103099781A Liposome, a pharmaceutical composition comprising the liposome, and a method of delivering active agents to a target site using the liposome |
05/15/2013 | CN103099780A Preparation method of hydrogen-microbubble-containing aqueous solution, and product and application of method |
05/15/2013 | CN103099604A An imaging method of tumor targeting based on enhancement effect of zinc ion signals |
05/14/2013 | US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
05/14/2013 | US8440623 Polymer stabilized neuropeptides |
05/14/2013 | US8440622 Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel) |
05/14/2013 | US8440170 Orally disintegrating tablets with speckled appearance |
05/14/2013 | US8440168 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
05/14/2013 | US8440167 Multimodal imaging of atherosclerotic plaque targeted to LOX-1 |
05/14/2013 | CA2642779C Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application |
05/14/2013 | CA2563692C Compositions and methods for enhancing contrast in imaging |
05/10/2013 | WO2013065002A1 Combination of a nanoparticle comprising a charged core made of phospholipid with a protein - use for the in vitro delivery of said protein |
05/10/2013 | WO2013038271A4 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell |
05/10/2013 | WO2012177701A3 Compositions, methods of synthesis and use of carbohydrate targeted agents |
05/10/2013 | CA2854131A1 Use of an anti-.alpha.-synuclein antibody to diagnose an elevated level of .alpha.-synuclein in the brain |
05/09/2013 | US20130116554 X-ray imaging at low contrast agent concentrations and/or low dose radiation |
05/09/2013 | US20130115172 Magnetic nanophosphor having core/shell structure and the synthetic method thereof |
05/09/2013 | US20130115171 Nav1.7-related assays |
05/09/2013 | US20130115170 Gm1-like peptides and uses thereof |
05/09/2013 | US20130115167 Peptides that home to atherosclerotic plaques and methods of use |
05/08/2013 | EP2589391A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
05/08/2013 | EP2589377A2 Microvesicles derived from cell protoplast, and use thereof |
05/08/2013 | EP2589343A1 Metal mixes for use in epicutaneous patch test |
05/08/2013 | EP2588145A1 Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (mpi) |
05/08/2013 | EP2588144A2 Detecting targets using mass tags and mass spectrometry |
05/08/2013 | EP2588078A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
05/08/2013 | CN103096935A Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
05/08/2013 | CN103096866A Kit and method for detecting porous dental hydroxy apatite |